Is prolonged stimulation of bone growth a therapeutic possibility?
Mundy
G R
GR
Division of Endocrinology and Metabolism, University of Texas Health Science Center, San Antonio.
D000375:Aging / Q000502:physiology; D019485:Bone Morphogenetic Proteins; D001861:Bone Regeneration / Q000187:drug effects*; D001862:Bone Resorption / Q000188:drug therapy*; D002116:Calcitonin / Q000494:pharmacology / Q000627:therapeutic use; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D005459:Fluorides / Q000494:pharmacology / Q000627:therapeutic use; D050723:Fractures, Bone / Q000188:drug therapy; D006133:Growth Substances / Q000494:pharmacology / Q000627:therapeutic use; D006728:Hormones / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D010006:Osteoblasts / Q000187:drug effects; D010010:Osteoclasts / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy*; D011506:Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects
D019485:Bone Morphogenetic Proteins; D004164:Diphosphonates; D006133:Growth Substances; D006728:Hormones; D011506:Proteins; D002116:Calcitonin; D005459:Fluorides